← back to search

Ilio Vitale

Istituti di Ricovero e Cura a Carattere Scientifico ·
Area of research
Oncology · Cell Biology
Research interest
Research interests include Microtubule and mitosis dynamics, DNA Repair Mechanisms, Cancer Treatment and Pharmacology, and Cancer-related Molecular Pathways.
h-index
61
citations
35,848
works
212
NIH funding
primary concept
Biology
email

Recent publications

Epigenetic regulation of cancer stemness
Signal Transduction and Targeted Therapy 2025cited by 25position: lastdoi
The hallmarks of cancer immune evasion
Cancer Cell 2024cited by 442position: middledoi
Epigenetic control of immunoevasion in cancer stem cells
Trends in cancer 2024cited by 16position: middledoi
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Cell Death and Differentiation 2023cited by 344position: firstdoi
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Nature Immunology 2022cited by 115position: middledoi
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Nature Medicine 2021cited by 830position: firstdoi
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides
Trends in cancer 2021cited by 74position: firstdoi
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer 2020cited by 1,043position: middledoi
Macrophages and Metabolism in the Tumor Microenvironment
Cell Metabolism 2019cited by 1,842position: firstdoi
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Nature Immunology 2019cited by 373position: middledoi
Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy
Trends in Cell Biology 2019cited by 100position: firstdoi
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Cell Death and Differentiation 2018cited by 6,413position: middledoi
Oncogene-induced senescence and tumour control in complex biological systems
Cell Death and Differentiation 2018cited by 164position: lastdoi
DNA Damage in Stem Cells
Molecular Cell 2017cited by 374position: firstdoi
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Science 2015cited by 434position: middledoi
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Nature Medicine 2014cited by 1,022position: middledoi
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
Cell Death and Differentiation 2014cited by 1,014position: middledoi
Consensus guidelines for the detection of immunogenic cell death
OncoImmunology 2014cited by 818position: middledoi
Systems biology of cisplatin resistance: past, present and future
Cell Death and Disease 2014cited by 773position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lorenzo Galluzzi · University of Plymouth11 papers (2014–2025) · 4 papers (2017–2025)Claudia Galassi · Cornell University3 papers (2024–2025)Guido Kroemer · Institut National du Cancer3 papers (2014–2019)Manel Esteller · Hospital de Sant Pau2 papers (2024–2025)Baldur Sveinbjørnsson · Karolinska Institutet1 papers (2021–2021)Takahiro Yamazaki · Cornell University1 papers (2021–2021)Kevin J. Harrington · NIHR Biomedical Research Centre at The Royal Marsden and the ICR1 papers (2019–2019)Timothy A. Chan · Cleveland Clinic1 papers (2024–2024)Nils-Petter Rudqvist · Io Therapeutics (United States)1 papers (2019–2019)Zlatko Trajanoski · Austrian Drug Screening Institute (Austria)1 papers (2019–2019)Annick Harel‐Bellan · Université Claude Bernard Lyon 11 papers (2014–2014)György Szabadkai · University College London1 papers (2014–2014) · 1 papers (2021–2021)Judith Michels · Inserm1 papers (2014–2014)Sherene Loi · Peter MacCallum Cancer Centre1 papers (2021–2021)Lisa M. Coussens · Cancer Research Center1 papers (2019–2019)Ignacio Melero · Breast Cancer Research Foundation1 papers (2019–2019) · 1 papers (2014–2014)Ruggero De Maria · Università Cattolica del Sacro Cuore1 papers (2017–2017)